Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Schering-Plough Corporation has announced that it plans to adopt a new global model for its clinical trial operations. Under the new model all clinical trials will be held to a consistent set of standards regardless of trial type, phase or geography.
Subscribe to our email newsletter
The company said that its global clinical operations (GCO) unit will establish this global set of standards, policies and practices, and build a management system that will oversee clinical trials worldwide.
This model is designed to enhance how the company plans and manages the progression of therapeutic compounds through clinical trials toward commercialization.
“When fully implemented, the new model we are adopting is designed to result in a global, standardized approach to how we conduct clinical trials,” said Brent Saunders, senior vice president of global compliance and business practices, and project executive chair. “This new model, which replaces a previously decentralized approach, should help ensure better planning and prioritization, greater consistency in trial execution and improved cost efficiencies.”